{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:31:43Z","timestamp":1767904303391,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T00:00:00Z","timestamp":1279065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11926-010-0116-z","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T02:49:14Z","timestamp":1278989354000},"page":"363-369","source":"Crossref","is-referenced-by-count":54,"title":["Interstitial Lung Disease in Rheumatoid Arthritis"],"prefix":"10.1007","volume":"12","author":[{"given":"Dana P.","family":"Ascherman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,14]]},"reference":[{"key":"116_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e3282f798ed","volume":"20","author":"C Nannini","year":"2008","unstructured":"Nannini C, Ryu JH, Matteson EL: Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 2008, 20:340\u2013346.","journal-title":"Curr Opin Rheumatol"},{"key":"116_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/art.10897","volume":"48","author":"EK Rasch","year":"2003","unstructured":"Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC: Prevalence of rheumatoid arthritis in persons 60\u00a0years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003, 48:917\u2013926.","journal-title":"Arthritis Rheum"},{"key":"116_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1513\/pats.200703-045MS","volume":"4","author":"KK Brown","year":"2007","unstructured":"Brown KK: Rheumatoid lung disease. Proc Am Thorac Soc 2007, 4:443\u2013448.","journal-title":"Proc Am Thorac Soc"},{"key":"116_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"\u2022\u2022 Gochuico BR, Avila NA, Chow CK, et al.: Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008, 168:159\u2013166. Through the use of multiplex ELISA-based technology, this study examined the relationship between levels of various cytokines\/chemokines in bronchoalveolar lavage fluid and subtype of RA-ILD, demonstrating that specific cytokine profiles predict radiographic progression in \u201csubclinical\u201d RA-ILD.","journal-title":"Arch Intern Med"},{"key":"116_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009740701393957","volume":"36","author":"ZM Metafratzi","year":"2007","unstructured":"Metafratzi ZM, Georgiadis AN, Ioannidou CV, et al.: Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007, 36:338\u2013344.","journal-title":"Scand J Rheumatol"},{"key":"116_CR6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","volume":"46","author":"A Young","year":"2007","unstructured":"Young A, Koduri G, Batley M, et al.: Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007, 46:350\u2013357.","journal-title":"Rheumatology (Oxford)"},{"key":"116_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10067-005-1158-x","volume":"25","author":"FF Ayhan-Ardic","year":"2006","unstructured":"Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, et al.: Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 2006, 25:213\u2013218.","journal-title":"Clin Rheumatol"},{"key":"116_CR8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.54.10.815","volume":"54","author":"B Cortet","year":"1995","unstructured":"Cortet B, Flipo RM, Remy-Jardin M, et al.: Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54:815\u2013819.","journal-title":"Ann Rheum Dis"},{"key":"116_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002960050093","volume":"19","author":"R Demir","year":"1999","unstructured":"Demir R, Bodur H, Tokoglu F, et al.: High resolution computed tomography of the lungs in patients with rheumatoid arthritis. Rheumatol Int 1999, 19:19\u201322.","journal-title":"Rheumatol Int"},{"key":"116_CR10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R, et al.: Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997, 156:528\u2013535.","journal-title":"Am J Respir Crit Care Med"},{"key":"116_CR11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3899\/jrheum.080882","volume":"36","author":"AN Georgiadis","year":"2009","unstructured":"Georgiadis AN, Metafratzi ZM, Drosos AA: Pulmonary abnormalities in patients with early and longstanding rheumatoid arthritis. J Rheumatol 2009, 36:444\u2013445; author reply 445\u2013446.","journal-title":"J Rheumatol"},{"key":"116_CR12","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1517\/14656560802591430","volume":"9","author":"C Kelly","year":"2008","unstructured":"\u2022 Kelly C, Saravanan V: Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opin Pharmacother 2008, 9:3221\u20133230. In addition to reviewing therapeutic approaches for RA-ILD, this article further defines the radiographic, histopathologic, and epidemiologic characteristics of this extra-articular complication.","journal-title":"Expert Opin Pharmacother"},{"key":"116_CR13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"\u2022\u2022 Kim EJ, Elicker BM, Maldonado F, et al.: Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010, 35:1322\u20131328. This study suggests that UIP is the most common subtype of RA-ILD, with a poor prognosis paralleling that of IPF.","journal-title":"Eur Respir J"},{"key":"116_CR14","first-page":"1513","volume":"35","author":"S Mori","year":"2008","unstructured":"\u2022\u2022 Mori S, Cho I, Koga Y, Sugimoto M: Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008, 35:1513\u20131521. This prospective study of 126 patients with early and late RA demonstrates significant rates of specific HRCT abnormalities that define radiographic categories corresponding to NSIP, UIP, cryptogenic organizing pneumonia, and bronchiolitis. Equally important, these radiographically defined subtypes are associated with characteristic pulmonary function test abnormalities.","journal-title":"J Rheumatol"},{"key":"116_CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","volume":"232","author":"N Tanaka","year":"2004","unstructured":"Tanaka N, Kim JS, Newell JD, et al.: Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004, 232:81\u201391.","journal-title":"Radiology"},{"key":"116_CR16","unstructured":"\u2022 Koduri G, Norton S, Young A, et al.: Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 2010 Mar 11 (Epub ahead of print). In this large inception cohort of patients with RA observed for up to 20\u00a0years (median follow-up period, 10\u00a0years), the authors determined that the annualized incidence of clinically evident RA-ILD was 4.1 per 1000 people. More significantly, this study indicates that the mortality rate among patients with clinically evident RA-ILD is greater than 50%, with a median survival of 3\u00a0years."},{"key":"116_CR17","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"\u2022\u2022 Bongartz T, Nannini C, Medina-Velasquez YF, et al.: Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population based study. Arthritis Rheum 2010, 62:1583\u20131591. This important population-based study from Olmstead County, MN, provides a detailed quantitative analysis of mortality attributable to RA-ILD, indicating that the percent of excess mortality in RA due to ILD is comparable to rates associated with congestive heart failure. The authors also demonstrate that older age, male gender, and increased articular disease severity correlate with the development of RA-ILD.","journal-title":"Arthritis Rheum"},{"key":"116_CR18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00152607","volume":"33","author":"KM Antoniou","year":"2009","unstructured":"\u2022 Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM: Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009, 33:882\u2013896. This review evaluates the radiographic incidence of RA-ILD and the impact of this pulmonary complication on mortality in RA.","journal-title":"Eur Respir J"},{"key":"116_CR19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","volume":"61","author":"JK Dawson","year":"2002","unstructured":"Dawson JK, Fewins HE, Desmond J, et al.: Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002, 61:517\u2013521.","journal-title":"Ann Rheum Dis"},{"key":"116_CR20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","volume":"21","author":"SM Naz","year":"2007","unstructured":"Naz SM, Symmons DP: Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007, 21:871\u2013883.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"116_CR21","first-page":"209","volume":"33","author":"H Toyoshima","year":"1993","unstructured":"Toyoshima H, Kusaba T, Yamaguchi M: [Cause of death in autopsied RA patients]. Ryumachi 1993, 33:209\u2013214.","journal-title":"Ryumachi"},{"key":"116_CR22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-2007-985609","volume":"28","author":"KO Leslie","year":"2007","unstructured":"Leslie KO, Trahan S, Gruden J: Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007, 28:369\u2013378.","journal-title":"Semin Respir Crit Care Med"},{"key":"116_CR23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"HK Lee","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, et al.: Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127:2019\u20132027.","journal-title":"Chest"},{"key":"116_CR24","doi-asserted-by":"crossref","unstructured":"Brusselle G: Rheumatoid arthritis and interstitial lung disease: a dangerous liaison. Rheumatology (Oxford) 2010 Mar 11 (Epub ahead of print).","DOI":"10.1093\/rheumatology\/keq017"},{"key":"116_CR25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","volume":"136","author":"EJ Kim","year":"2009","unstructured":"\u2022 Kim EJ, Collard HR, King TE Jr: Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009, 136:1397\u20131405. This article focuses on the relationship between HRCT findings and histologic subtype of RA-ILD. Based on this correlation between radiographic abnormalities and histopathology, the authors propose an algorithm for screening and monitoring of RA-ILD.","journal-title":"Chest"},{"key":"116_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-004-0527-0","volume":"26","author":"T Yoshinouchi","year":"2005","unstructured":"Yoshinouchi T, Ohtsuki Y, Fujita J, et al.: Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005, 26:121\u2013125.","journal-title":"Rheumatol Int"},{"key":"116_CR27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejrad.2008.07.008","volume":"72","author":"K Marten","year":"2009","unstructured":"\u2022 Marten K, Dicken V, Kneitz C, et al.: Computer-assisted quantification of interstitial lung disease associated with rheumatoid arthritis: preliminary technical validation. Eur J Radiol 2009, 72:278\u2013283. In this interesting analysis, the authors used computerized quantification of HRCT abnormalities to demonstrate correlations with pulmonary function parameters that include D L CO and FVC.","journal-title":"Eur J Radiol"},{"key":"116_CR28","first-page":"1250","volume":"33","author":"A Rajasekaran","year":"2006","unstructured":"Rajasekaran A, Shovlin D, Saravanan V, et al.: Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5\u00a0years. J Rheumatol 2006, 33:1250\u20131253.","journal-title":"J Rheumatol"},{"key":"116_CR29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park JH, Kim DS, Park IN, et al.: Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007, 175:705\u2013711.","journal-title":"Am J Respir Crit Care Med"},{"key":"116_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, et al.: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38\u201346.","journal-title":"Arthritis Rheum"},{"key":"116_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","volume":"350","author":"S Nijenhuis","year":"2004","unstructured":"Nijenhuis S, Zendman AJ, Vossenaar ER, et al.: Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 2004, 350:17\u201334.","journal-title":"Clin Chim Acta"},{"key":"116_CR32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren AK, et al.: Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 67:1488\u20131492.","journal-title":"Ann Rheum Dis"},{"key":"116_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","volume":"46","author":"T Bongartz","year":"2007","unstructured":"Bongartz T, Cantaert T, Atkins SR, et al.: Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:70\u201375.","journal-title":"Rheumatology (Oxford)"},{"key":"116_CR34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10067-007-0800-1","volume":"27","author":"I Alexiou","year":"2008","unstructured":"Alexiou I, Germenis A, Koutroumpas A, et al.: Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008, 27:511\u2013513.","journal-title":"Clin Rheumatol"},{"key":"116_CR35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinbiochem.2008.06.014","volume":"41","author":"N Inui","year":"2008","unstructured":"Inui N, Enomoto N, Suda T, et al.: Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 2008, 41:1074\u20131077.","journal-title":"Clin Biochem"},{"key":"116_CR36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/ars.2007.1897","volume":"10","author":"BD Bringardner","year":"2008","unstructured":"Bringardner BD, Baran CP, Eubank TD, Marsh CB: The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008, 10:287\u2013301.","journal-title":"Antioxid Redox Signal"},{"key":"116_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","volume":"2","author":"MS Wilson","year":"2009","unstructured":"Wilson MS, Wynn TA: Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009, 2:103\u2013121.","journal-title":"Mucosal Immunol"},{"key":"116_CR38","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1371\/journal.pmed.0020251","volume":"2","author":"A Pardo","year":"2005","unstructured":"Pardo A, Gibson K, Cisneros J, et al.: Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005, 2:e251.","journal-title":"PLoS Med"},{"key":"116_CR39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1513\/pats.200601-010TK","volume":"3","author":"C Agostini","year":"2006","unstructured":"Agostini C, Gurrieri C: Chemokine\/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:357\u2013363.","journal-title":"Proc Am Thorac Soc"},{"key":"116_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.anndiagpath.2008.10.001","volume":"12","author":"RN Rao","year":"2008","unstructured":"Rao RN, Goodman LR, Tomashefski JF Jr: Smoking-related interstitial lung disease. Ann Diagn Pathol 2008, 12:445\u2013457.","journal-title":"Ann Diagn Pathol"},{"key":"116_CR41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","volume":"39","author":"KG Saag","year":"1996","unstructured":"Saag KG, Kolluri S, Koehnke RK, et al.: Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996, 39:1711\u20131719.","journal-title":"Arthritis Rheum"},{"key":"116_CR42","first-page":"409","volume":"2","author":"AJ Thorley","year":"2007","unstructured":"Thorley AJ, Tetley TD: Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2:409\u2013428.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"116_CR43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138920008785821684","volume":"9","author":"Q Yang","year":"2008","unstructured":"Yang Q, Underwood MJ, Hsin MK, et al.: Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab 2008, 9:661\u2013667.","journal-title":"Curr Drug Metab"},{"key":"116_CR44","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","volume":"5","author":"IO Rosas","year":"2008","unstructured":"Rosas IO, Richards TJ, Konishi K, et al.: MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008, 5:e93.","journal-title":"PLoS Med"},{"key":"116_CR45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.rmed.2004.04.003","volume":"98","author":"F Kinoshita","year":"2004","unstructured":"Kinoshita F, Hamano H, Harada H, et al.: Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respir Med 2004, 98:1131\u20131137.","journal-title":"Respir Med"},{"key":"116_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/PL00007584","volume":"175","author":"T Oyama","year":"1997","unstructured":"Oyama T, Kohno N, Yokoyama A, et al.: Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 1997, 175:379\u2013385.","journal-title":"Lung"},{"key":"116_CR47","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","volume":"168","author":"LA Saketkoo","year":"2008","unstructured":"Saketkoo LA, Espinoza LR: Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Arch Intern Med 2008, 168:1718\u20131719.","journal-title":"Arch Intern Med"},{"key":"116_CR48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/03009740600844381","volume":"35","author":"A Afeltra","year":"2006","unstructured":"Afeltra A, Zennaro D, Garzia P, et al.: Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol 2006, 35:388\u2013394.","journal-title":"Scand J Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-010-0116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0116-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:53Z","timestamp":1559436593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-010-0116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,14]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1007\/s11926-010-0116-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,14]]}}}